Emerging Trends in Lysosomal Biology & Lysosomal Diseases: STATE-OF-THE-ART FOR EXPERTS

Monday, February 4, 2019 from 1:00 – 5:00 PM

For the seventh consecutive year, WORLDSymposium begins with “Emerging Trends” on Monday afternoon, February 4, 2019 at 1:00 PM. This 4-hour CME course provides a state-of-the-art update for experts working in lysosomal biology and lysosomal diseases. This course is a summary of the latest research trends and other advances in the field.

Seasoned researchers provide a global review of the past years’ advances, a state-of-the-art overview of lysosome biology, diseases and therapies. This review evolves every year, providing a summary of the latest research trends, new knowledge, and other discoveries. The course is intended for researchers and health care practitioners who are interested in being current on recent advances in the basic science, diagnosis, and treatment of lysosomal diseases. This course is taught at the postgraduate level, e.g., those with a PhD, MD, PharmD, DDS, MS, MPH, etc.

The content provides comprehensive information on lysosomal diseases, but does not overlap or replace the scientific data being presented during WORLDSymposium 2019. Registration Required.

Learning Objectives

Upon completion of this educational activity, the participant should be better able to:

  1. Describe the basic structure, function and molecular biology of lysosomes.
  2. Identify specific lysosomal diseases, their clinical manifestations, and means of diagnosis.
  3. Review current treatments for lysosomal diseases, the potential side effects, and their expected clinical outcomes.
  4. Correlate the molecular biology of lysosomes with clinical features, diagnostic testing, and treatment approaches.

Preliminary Agenda

1:00 PM
Introduction and Overview of Course
Chester B. Whitley, PhD, MD

1:10 PM
Lysosomal Disease Phenotypes
Chester B. Whitley, PhD, MD

1:35 PM
Normal Lysosomal Function
Steven U. Walkley, DVM, PhD

2:00 PM
Break

2:05 PM
Remarkable Cases I
Marc C. Patterson, MD

2:30 PM
Lysosomal Disease Pathogenesis
Steven U. Walkley, DVM, PhD

2:55 PM
Refreshment Break

3:10 PM
Current Treatments for Lysosomal Diseases
Jeanine R. Jarnes, PharmD

3:35 PM
Newborn Screening
Amy Gaviglio, MS, LCGC

4:00 PM
Break

4:05 PM
Future Treatments for Lysosomal Diseases
Jeanine R. Jarnes, PharmD

4:30 PM
Remarkable Cases II
Marc C. Patterson, MD

4:55 PM
Final Evaluation
Chester B. Whitley, PhD, MD

5:00 PM
Adjourn

Invited Faculty

Chair: Chester B. Whitley, PhD, MD
Course Director
WORLDSymposium and “Emerging Trends: State-of-the-Art for Experts”
Professor, Department of Pediatrics, and
Experimental and Clinical Pharmacology
University of Minnesota
Principal Investigator, Lysosomal Disease Network
Minneapolis, MN, USA

Steven U. Walkley, DVM, PhD
Director, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center
Head, Sidney Weisner Laboratory of Genetic Neurological Disease
Departments of Neuroscience, Pathology and Neurology
Rose F. Kennedy Center
Albert Einstein College of Medicine
Bronx, NY, USA

Marc C. Patterson, MD, FRACP
Professor of Neurology, Pediatrics and Medical Genetics
Editor-in-Chief, Journal of Child Neurology and Child Neurology Open
Editor, Journal of Inherited Metabolic Disease and JIMD Reports
Mayo Clinic Children’s Center
Rochester, MN, USA

Jeanine R. Jarnes, PharmD, BCOP, BCPS
Adjunct Assistant Professor, Experimental and Clinical Pharmacology
College of Pharmacy
University of Minnesota, Fairview
Minneapolis, MN, USA

Amy Gaviglio, MS, LCGC
Follow-Up Supervisor and Licensed Genetic Counselor
Newborn Screening Program
Minnesota Department of Health
St. Paul, MN

2019 ACCME Accreditation

Postgraduate Institute for Medicine
WORLDSymposium 2019 is jointly provided by Postgraduate Institute for Medicine and WORLDSymposia.

Target Audience:
This activity ha been designed for geneticists, pediatricians, primary care practitioners, registered nurses, nurse practitioners, physician assistants, genetic counselors, and other researchers and health care practitioners involved with the identification of disease mechanisms and potential treatments, or involved with the diagnosis and management of individuals with lysosomal diseases. In addition, the content is designed to be applicable to individuals with lysosomal diseases and their family members, as well as advocacy groups involved with raising awareness.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and WORLDSymposia. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.5 contact hours.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act
Americans with Disabilities ActEvent staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Gudrun Echterhoff prior to the live event at gudrun@nullgmimeetings.com